- March 22: The European Medicines Verification Organization (EMVO) and various National Medicines Verification Organizations (NMVOs) published announcements regarding staff working from home and the continued availability of services during the COVID-19 crisis. No changes to stabilization periods or alert management processes have been announced.
- March 22: Switzerland expects feedback on the public consultation for Article 17a—the Swiss implementation of the European Union Falsified Medicines Directive (EU FMD)—to be submitted in late March or early April. But the law is not expected to go into effect before 2021. EU FMD compliance in Switzerland is currently optional.
- March 22: Latvia’s NMVO published new content with EU FMD guidance for the general public, including a “customer journey” video that illustrates the verification and decommissioning procedure that patients are likely to encounter at local pharmacies.